The ACR has released a summary of a new 2024 guideline for the screening, treatment, and management of Lupus Nephritis.

Acrux Limited (AU:ACR) has released an update.Don't Miss Our Christmas Offers:Discover the latest stocks recommended by top Wall Street ...

If you’re thinking of buying a “smart” TV for the holidays, you ought to know that your new device is constantly capturing ...

In this series of articles where we review the most acclaimed Vipers, today we have a date with the 2016 Viper ACR. An ...

The U.S. House of Representatives voted Dec. 16, to advance the Women and Lung Cancer Research and Preventive Services Act of 2024 (H.R. 4534), legislation supported by the American College of ...

If you were an American amateur racing fan in the 1990s, the Neon Challenge needs no introduction. This single-make race ...

Acrivon Therapeutics develops innovative cancer therapies with companion diagnostics. Read why ACRV stock has upside ...

The Centers for Medicare and Medicaid Services (CMS) began transitioning participation in the traditional Merit-based Incentive Payment System (MIPS) to MIPS Value Pathways (MVPs) in 2023 to reduce ...

Despite following the same basic recommendations as the adult guidelines, the pediatric LN guidelines included special ...

ACR 2024 highlighted new guidelines for the screening, treatment, and management of lupus nephritis, stressing prompt kidney biopsy and timely treatment.